- €2.92bn
- €4.87bn
- €5.13bn
- 53
- 68
- 44
- 56
Annual balance sheet for Solvay SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,002 | 941 | 932 | 584 | 539 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,823 | 3,729 | 3,614 | 1,331 | 1,241 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,484 | 6,833 | 7,010 | 2,714 | 2,451 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 5,122 | 5,409 | 5,785 | 2,411 | 2,414 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 16,792 | 20,049 | 20,661 | 7,022 | 6,694 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,775 | 5,531 | 4,885 | 2,192 | 1,888 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 9,594 | 11,310 | 10,058 | 5,759 | 5,355 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 7,198 | 8,739 | 10,603 | 1,263 | 1,339 |
| Total Liabilities & Shareholders' Equity | 16,792 | 20,049 | 20,661 | 7,022 | 6,694 |
| Total Common Shares Outstanding |